MRI assessment of aortic flow in patients with pulmonary arterial hypertension in response to exercise
While primarily a right heart disease, pulmonary arterial hypertension (PAH) can impact left heart function and aortic flow through a shifted interventricular septum from right ventricular pressure overload and reduced left ventricular preload, among other mechanisms. In this study, we used phase contrast (PC) MRI and a modest exercise challenge to examine the effects of PAH on systemic circulation. While exercise challenges are typically performed with ultrasound in the clinic, MRI exercise studies allow for more reproducible image alignment, more accurate flow quantification, and improved tissue contrast.
Six PAH patients and fifteen healthy controls (8 older age-matched, 7 younger) exercised in the magnet bore with an MRI-compatible exercise device that allowed for scanning immediately following cessation of exercise. PC scans were performed in the ascending aorta during a breath hold immediately after modest exercise to non-invasively measure stroke volume (SV), cardiac output (CO), aortic peak systolic flow (PSF), and aortic wall stiffness via relative area change (RAC).
Images following exercise showed mild blurring, but were high enough quality to allow for segmentation of the aorta. While SV was approximately 30% lower in PAH patients (SVPAH,rest = 67 ± 16 mL; SVPAH,stress = 90 ± 42 mL) than age-matched controls (SV,older,rest = 93 ± 16 mL; SVolder,stress = 133 ± 40 mL) at both rest and following exercise, CO was similar for both groups following exercise (COPAH,stress = 10.8 ± 5.7 L/min; COolder,stress = 11.8 ± 5.0 L/min). This was achieved through a compensatory increase in heart rate in the PAH subjects (74% increase as compared to 29% in age-matched controls). The PAH subjects also demonstrated reduced aortic peak systolic flow relative to the healthy controls (PSFPAH,rest = 309 ± 52 mL/s; PSFolder,rest = 416 ± 114 mL/s; PSFPAH,stress = 388 ± 113 mL/s; PSFolder,stress = 462 ± 176 mL/s). PAH patients and older controls demonstrated stiffer aortic walls when compared to younger controls (RACPAH,rest = 0.15 ± 0.05; RAColder,rest = 0.17 ± 0.05; RACyoung,rest = 0.28 ± 0.08).
PC MRI following a modest exercise challenge was capable of detecting differences in left heart dynamics likely induced from PAH. These results demonstrated that PAH can have a significant influence on systemic flow, even when the patient has no prior left heart disease. Image quantification following exercise could likely be improved in future studies through the implementation of free-breathing or real-time MRI acquisitions.
Retrospectively registered on 02/26/2018 (TRN:NCT03523910).
KeywordsExercise Pulmonary arterial hypertension Stress test Flow MRI
Magnetic resonance imaging
Pulmonary arterial hypertension
Peak systolic flow
Peak systolic velocity
Pulse wave velocity
Relative area change
Single photon emission computer tomography
World Health Organization
It is well established that stress tests can reveal important diagnostic information beyond that seen with tests performed at a resting heart rate [1, 2, 3, 4], such as ischemia, increased ventricular pressures, valvular regurgitation, and deficiencies in recovery to a resting state. In clinical settings, exercise tests are commonly performed with an exercise paradigm on a treadmill or stationary bicycle followed by echocardiography  or single photon emission computed tomography (SPECT) image acquisitions .
Cardiopulmonary exercise testing is increasingly used to assess disease progression in patients with pulmonary hypertension (PH) [6, 7, 8]. PH is characterized by an increase in blood pressure in the pulmonary vasculature, which can be caused by or result in vascular remodeling and stiffening of the pulmonary artery [9, 10]. While some cases of PH are the end result of left-sided heart disease that directly influence systemic circulation (World Health Organization (WHO) functional group 2) , pulmonary arterial hypertension (PAH; WHO functional group 1) is the result of conditions, such as connective tissue diseases, acting directly on the pulmonary vasculature . In these cases, although there is no initial left heart dysfunction, right ventricular pressure overload induced by PAH can lead to a shift or distortion of the interventricular septum [13, 14, 15]. Left heart dynamics in these patients may also be altered by reduced left ventricular (LV) preload as a result of inhibited right heart flow , increased vascular impedance from stiffening of the aorta , and co-existing systemic hypertension . These factors may lead to a reduced LV volume in PAH patients relative to a healthy population, which in turn may lead to diminished stroke volume and cardiac output.
PH screening and assessment is clinically performed with echocardiography, which is limited in its capabilities due to its short penetration depth  and difficulty in properly aligning the acoustic window with the arterial flow . In addition, Doppler ultrasound does not directly measure flow, but instead produces estimates from velocity measurements and pre-established vessel area models, which can introduce systematic errors into flow estimates .
Magnetic resonance imaging (MRI) provides the opportunity for more accurate visualization and quantification of flow via phase contrast (PC) acquisitions. MRI allows for less dependency on the skill of the operator as a result of improved spatial resolution, larger imaging windows, and higher tissue contrast. Recent work has also demonstrated that non-invasive measures of arterial stiffness are possible with PC MRI through metrics such as pulse wave velocity (PWV) and the relative area change (RAC) of the artery between diastole and systole .
Despite the advantages MRI could offer over existing exercise imaging modalities in assessing pulmonary hypertension, exercise MRI is challenging because of the relatively slow acquisition speed and the narrow confinements of the magnet bore. Instead, pharmacological stress agents, such as Dobutamine, Adenosine, and Regadenoson [23, 24, 25], are used in clinical practice. The drawback of such techniques is that pharmacological stress is not physiologic and, therefore, is not the preferred method of stress for assessing pulmonary hypertension [1, 26]. In response to these shortcomings, recent advances have seen the development of MRI-compatible exercise devices that allow for exercise in the MRI room adjacent to the table  or in a supine position on the scanner bed inside the magnet bore [28, 29, 30].
Overall, while it is likely that a patient diagnosed with PAH will experience diminished left heart function due to factors such as right ventricular pressure overload or reduced LV preload during the progression of the disease, such effects have not been investigated in detail with exercise MRI. Previous work has performed straightforward comparisons of blood flow in the aorta of PAH patients with controls using PC MRI , but has not correlated these measurements with metrics of vessel stiffness or investigated the value of exercise studies for these comparisons. The goal of this study was to use a custom-made, MRI-compatible exercise device to examine the effects of pulmonary arterial hypertension on aortic flow and stiffness in response to exercise with PC MRI. We hypothesize that PH subjects will show reduced left heart efficiency (lower stroke volume, higher heart rate) relative to healthy controls and these differences will be more pronounced following exercise stress.
This study was approved by the local Institutional Review Board and was compliant with the Health Insurance Portability and Accountability Act. Twenty-one subjects were recruited, provided written informed consent, and were screened via an MRI safety questionnaire. The 21 subjects were divided into 3 cohorts: 7 young, healthy controls (28 ± 4 years; 3 male, 4 female), 8 older, healthy controls (58 ± 10 years; 1 male, 7 female), and 6 pulmonary hypertension patients (WHO Group 1 (PAH) from systemic sclerosis, 60 ± 9 years; 1 male, 5 female). All control subjects were free of overt cardiovascular, pulmonary, and renal disease. The recruited PH subjects had no recent syncope and, like the controls, had no history of unassociated lung or cardiovascular disease. Exclusion criteria for this study included classification as New York Heart Association functional class IV (symptoms of limited cardiac capacity apparent at rest) and skeletal or muscle abnormalities which could prohibit exercise. The older, healthy control group was age-matched to the PH group. The younger control group was included to provide insight regarding loss of cardiac function via disease versus natural loss due to aging. Subjects were excluded from the final statistical analysis if image quality was too poor to delineate the aortic wall or if the subject moved out of the prescribed scanning planes during exercise.
MRI-compatible exercise device
Imaging was performed on one of two clinical 1.5 T MRI systems (HDxt or Discovery 450w, GE Healthcare, Waukesha, WI) using an 8 channel cardiac coil and vector electrocardiographic (ECG) gating. Flow measurements were acquired with a prospectively ECG-gated two-dimensional (2D) cine phase contrast (PC) sequence performed across a 15 s breath hold. The imaging plane was prescribed orthogonal to the ascending aorta. Imaging parameters for the PC sequence were: field of view = 35 × 35 cm, matrix size = 128 × 256 (reconstructed to 256 × 256), slice thickness = 8 mm; TR/TE = 6.1/3.7 ms, flip angle = 30°, velocity encode (VENC) = 150 cm/s, parallel-imaging (ASSET) acceleration factor = 2, temporal resolution = 25 ms, and cardiac phases = 20.
Aortic flow measurements were performed with CV Flow (Version 3.3, Medis, Leiden, Netherlands) on a GE Advantage workstation. The following parameters were calculated from the flow measurements: stroke volume (SV), cardiac output (CO), peak systolic flow (PSF), peak systolic velocity (PSV), and the relative area change (RAC) of the ascending aorta between diastole and systole. Aortic stiffness was estimated with relative area change rather than pulse wave velocity due to the limited temporal resolution of the PC sequence.
All statistical analysis was performed with R (Version 3.2.3, R Foundation for Statistical Computing, Vienna, Austria). Results are presented as the mean value plus or minus one standard deviation of the sampled group. To determine the statistical significance of any intragroup changes between parameters measured at rest and stress, a paired student’s t-test was performed for each cohort. A one-way ANOVA test with a post-hoc Tukey’s honestly significant difference (HSD) test was used to determine statistically significant intergroup differences for each parameter at rest and stress. Levene’s test was used in conjunction with the ANOVA test to ensure that the assumption of equal variances between groups was valid. For all statistical tests, a threshold of α = 0.05 was chosen for statistical significance.
MRI exercise stress tests were successfully performed in 19/21 subjects. Two of the older, healthy controls shifted their body position during exercise such that the prescribed scan planes were not usable. Thus, they were omitted from the analysis. All subjects successfully completed the 15 s breath hold following exercise. Although the target exercise power for each group was 30 W, the actual exercise power achieved for the remaining young controls, older controls, and PH subjects was 38 ± 12 W, 32 ± 8 W, and 30 ± 10 W respectively. There was no statistically significant difference in the achieved exercise power between these groups (p = 0.29). These exercise powers resulted in an average heart rate increase of 46% for the young controls, 29% for the older controls, and 74% for the PH subjects.
Hemodynamic parameters measured in the ascending aorta at rest and immediately following exercise stress from phase contrast acquisitions. Results are presented as the mean value plus or minus one standard deviation of the samples
Heart rate [bpm]
66 ± 11
67 ± 9
69 ± 19
97 ± 19*
87 ± 12*
116 ± 19*
Stroke volume [mL]
96 ± 15
93 ± 16
67 ± 16
116 ± 23*
133 ± 40*
90 ± 42
Cardiac output [L/min]
6.3 ± 1.1
6.3 ± 1.6
4.5 ± 1.4
11 ± 2*
11.8 ± 5*
10.8 ± 5.7*
Peak systolic velocity [cm/s]
77 ± 21
58 ± 15
49 ± 14
78 ± 22
69 ± 27
68 ± 29*
Peak systolic flow [mL/s]
445 ± 85
416 ± 114
309 ± 52
446 ± 118
462 ± 176
388 ± 113
Relative area change
0.28 ± 0.08
0.17 ± 0.05
0.15 ± 0.05
0.28 ± 0.10
0.27 ± 0.14
0.25 ± 0.18
Measurements of peak systolic flow and peak systolic velocity showed no meaningful response to exercise in the young control groups. In contrast, the older controls showed a 19% increase in velocity and an 11% increase in flow in response to exercise. Likewise, the PH subjects demonstrated a larger 39% increase in velocity and 26% increase in flow. At both rest and exercise, the PH subjects demonstrated lower overall average values of these parameters when compared to both control groups (Fig. 4c, d).
As hypothesized, PH patients demonstrated reduced LV stroke volume at rest and during stress when compared to control groups. These reduced stroke volumes may suggest the presence of a shifted interventricular septum induced by right ventricular pressure overload, reduced LV preload, or a co-existing condition, such as systemic hypertension. Future studies with imaging sequences dedicated to ventricular imaging (e.g. balanced steady-state free precession MRI) and ventricular pressure measurements could prove valuable to elucidate the relative contributions of these factors to the reduced left heart SV in these patients. Despite low stroke volumes, however, the PH patients presented a preserved cardiac output following exercise as a result of a compensatory increase in heart rate (74% increase in PH subjects as compared to 29% in age-matched controls). Therefore, while PH patients may be able to match exercise capabilities of age-matched controls in the short-term, the more rapid increase in heart rate will result in PH patients reaching a clinically-defined maximum heart rate sooner, yielding reduced exercise endurance. This behavior in the left ventricle is consistent with right heart dynamics previously reported following exercise in patients with PH .
Although the exercise stress induced comparable levels of cardiac output in the PH population and both control groups, the PH subjects demonstrated reduced peak systolic velocity and peak systolic flow – further evidence of altered left heart hemodynamics induced by right heart changes from PAH. It is worth noting, however, that for these parameters the older control group showed decreased mean values relative to the younger group as well, suggesting the reduced capacity shown in the PH subjects may be a more complex dynamic between natural age-related loss of cardiovascular function and disease progression.
The relative area change of the aorta proved to be capable of assessing vessel stiffness, demonstrating reduced aortic compliance in the PH subjects relative to the controls. This result was consistent with the fact that the recruited patients developed PAH as a result of ongoing systemic sclerosis  and may have contributed to the reduced stroke volume and exercise capacity in this group. There is great value in future investigations to perform non-invasive measures in the pulmonary artery of the PH subjects to examine the extent of stiffening relative to the aorta.
The modest increase in heart rate observed across all three subject cohorts validated that the relatively low exercise power used in this study was still effective at inducing observable exercise stress in each cohort, although the cardiac response was diminished in the control groups. This demonstrated that mild exercise paradigms can be an effective method for stress imaging in subjects with reduced cardiac capacity. The drawback of using low exercise powers was observed in the younger controls, however, who were not as challenged by the paradigm and, on average, exercised at a power 25% above the targeted level. Since the resistance could be adjusted in real-time during exercise with the exercise equipment used for this study, in this case, where the young controls exercised faster than this metronome beat, there was no way to compensate and reduce their exercise power.
The potential value of performing exercise studies in a PH population was apparent, as the PH cohort showed larger relative responses to exercise than the healthy controls in all measured hemodynamic parameters except stroke volume, which is known to have a reduced response to exercise in PH subjects . Performing studies with increased exercise power may induce greater differences between these cohorts than observed with the mild exercise powers used in this study. The increased cardiac response to higher exercise powers in all cohorts would also likely result in statistically significant differences between rest and stress in many of the parameters that showed non-significant increases with exercise, such as peak systolic velocity and flow. Given the disparity in exercise abilities between these cohorts, in future studies, it would be valuable to standardize our comparisons on more physiologic measures of exercise, such as a common heart rate or maximal oxygen uptake (VO2,max), rather than a common exercise power.
While the breath held PC acquisitions were successfully completed in all subjects following exercise, some of the subjects with more limited cardiac output, expressed a greater perceived difficulty in accomplishing these breath holds. Body motion from discomfort during these breath holds may have contributed to the larger degree of blurring observed in these subjects’ images. Although more challenging for these subjects, it was essential to begin imaging immediately following exercise due to the rapid recovery of heart rate back to a resting state. The potential heart rate recovery across the 15 s of imaging following cessation of exercise was not deemed to be a concern, however, as a previous study showed that even in young athletes, heart rate will only decrease an average of 5% in this time period . In future studies, the implementation of free-breathing or real-time acquisitions could eliminate the need for a breath hold altogether and allow for imaging during exercise, resulting in a more comfortable exercise paradigm for subjects and a possible improvement in image quality.
There were a few limitations to this study beyond those already mentioned. The harness used to reduce chest motion was not entirely effective at preventing subject movement, as demonstrated with the two subjects who moved out of their prescribed scan planes. Motion such as this possibly led to shifts or rotations in scan planes in the other subjects, which could impact the accuracy of flow and vessel cross-sectional area measurements. In addition, the statistical power of our observations was limited by the relatively small sample size of each cohort. These factors likely contributed to increased variance and lack of statistical significance in some of the measurements.
In conclusion, we investigated the impact of pulmonary arterial hypertension on aortic flow with PC MRI following a modest exercise challenge. Custom-made, MR-compatible exercise equipment permitted subjects to exercise in a supine position fully in the bore of the scanner, allowing for imaging immediately following the cessation of exercise. As we hypothesized, the PH subjects showed reduced LV stroke volume and decreased cardiac efficiency relative to the healthy controls. The PH subjects demonstrated a different mechanism for increasing cardiac output in response to exercise, relying on large increases in heart rate rather than the balanced increase in heart rate and stroke volume observed in healthy controls. Cardiac output, peak systolic velocity, and peak systolic flow showed increased sensitivity to exercise-induced changes in the PH population, as well. Future studies will compare these metrics to those obtained from pulmonary flow in the same subject populations.
We gratefully acknowledge funding from the NIH and GE Healthcare for their research support and assistance.
Funding for this work was provided by the NIH (R01HL105598). The funding body had no role in the design of the study, the collection, analysis, and interpretation of data, or in writing the manuscript.
Availability of data and materials
The datasets used and analyzed during the current study are available from the corresponding author on reasonable request.
JAM analyzed and interpreted the MRI data and wrote the manuscript. CJF provided clinical perspective and guidance when designing the study, helped design the MRI scanning protocol, and helped interpret results. OF worked on stepper implementation and oversaw exercise challenges. NCC conceived the initial study design and obtained the grant funding this project. OW provided guidance on study design and helped design the MRI scanning protocol. All authors read and approved the final manuscript.
Ethics approval and consent to participate
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Before participation in the study, written informed consent was obtained from all individual subjects to participate in study activities and use their data in a research capacity. This study was approved by the University of Wisconsin-Madison Health Sciences Institutional Review Board (IRB 2011–0980; PI: Francois).
Consent for publication
The University of Wisconsin receives research support from GE Healthcare. The authors declare that they have no other potential competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
- 3.Pina IL, Balady GJ, Hanson P, Labovitz AJ, Madonna DW, Myers J. Guidelines for clinical exercise testing laboratories : a statement for healthcare professionals from the committee on exercise and cardiac rehabilitation. Am Heart Assoc Circ. 1995;91:912–21. https://doi.org/10.1161/01.CIR.91.3.912.
- 5.Bailey IK, Griffith LS, Rouleau J, Strauss HW, Pitt B. Thallium-201 myocardial perfusion imaging at rest and during exercise: comparative sensitivity to electrocardiography in coronary artery disease. Circulation. 1977;55:79–87. https://doi.org/10.1161/01.CIR.55.1.79.
- 7.Argiento P, Chesler N, Mule M, D’Alto M, Bossone E, Unger P, et al. Exercise stress echocardiography for the study of the pulmonary circulation. Eur Respir J. 2010;35:1273–8. https://doi.org/10.1183/09031936.00076009.
- 8.Naeije R, Chesler N. Pulmonary circulation at exercise. Compr Physiol. 2012;2:711–41. https://doi.org/10.1002/cphy.c100091
- 11.Kiefer TL, Bashore TM. Pulmonary hypertension related to left-sided cardiac pathology. Pulm Med. 2011. https://doi.org/10.1155/2011/381787.
- 12.Ungerer RG, Tashkin DP, Furst D, Clements PJ, Gong H, Bein M, et al. Prevalence and clinical correlates of pulmonary arterial hypertension in progressive systemic sclerosis. Am J Med. 1983;75:65–74. https://doi.org/10.1016/0002-9343(83)91169-5.
- 13.King ME, Braun H, Goldblatt a, Liberthson R, Weyman a E. Interventricular septal configuration as a predictor of right ventricular systolic hypertension in children: a cross-sectional echocardiographic study. Circulation. 1983;68:68–75. https://doi.org/10.1161/01.CIR.68.1.68.CrossRefPubMedGoogle Scholar
- 16.Gorter TM, Willems TP, Van Melle JP. Ventricular interdependence in pulmonary arterial hypertension: providing small pieces of a complex puzzle. Eur J Heart Fail. 2015;17:1–2. https://doi.org/10.1002/ejhf.195
- 17.Schäfer M, Ivy DD, Abman SH, Barker AJ, Browne LP, Fonseca B, et al. Apparent aortic stiffness in children with pulmonary arterial hypertension. Circ Cardiovasc Imaging. 2017;10:1–9. https://doi.org/10.1161/CIRCIMAGING.116.005817.
- 19.Peng H-H, Chung H-W, Yu H-Y, Tseng W-Y I. Estimation of pulse wave velocity in main pulmonary artery with phase contrast MRI: preliminary investigation. J Magn Reson Imaging. 2006;24:1303–10. https://doi.org/10.1002/jmri.20782.
- 20.Paz R, Mohiaddin RH, Longmore DB. Magnetic resonance assessment of the pulmonary arterial trunk anatomy, flow, pulsatility and distensibility. Eur Heart J. 1993;14:1524–30. https://doi.org/10.1093/eurheartj/14.11.1524.
- 21.Gill R. Measurement of blood flow by ultrasound: accuracy and sources of error. Ultrasound Med Biol. 1985;11:625–41. https://doi.org/10.1016/0301-5629(85)90035-3.
- 22.Forouzan O, Warczytowa J, Wieben O, François CJ, Chesler NC. Non-invasive measurement using cardiovascular magnetic resonance of changes in pulmonary artery stiffness with exercise. J Cardiovasc Magn Reson. 2015;17:109. https://doi.org/10.1186/s12968-015-0213-2.CrossRefPubMedPubMedCentralGoogle Scholar
- 23.Charoenpanichkit C, Hundley WG. The 20 year evolution of dobutamine stress cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2010;12:59.https://doi.org/10.1186/1532-429X-12-59.
- 24.Chotenimitkhun R, Gregory Hundley W. Pharmacological Stress Cardiovascular Magnetic Resonance. Postgrad Med. 2011;123:162–70. https://doi.org/10.3810/pgm.2011.05.2295.
- 26.Armstrong WF, Zoghbi WA. Stress echocardiography: current methodology and clinical applications. J Am Coll Cardiol. 2005;45:1739–47. https://doi.org/10.1016/j.jacc.2004.12.078.
- 27.Foster EL, Arnold JW, Jekic M, Bender J, Balasubramanian V, Thavendiranathan P, et al. An MR-compatible treadmill for exercise stress cardiac magnetic resonance imaging. Magn Reson Med. 2013;67:880–9. https://doi.org/10.1002/mrm.23059
- 30.Von Knobelsdorff-Brenkenhoff F, Dieringer MA, Fuchs K, Hezel F, Niendorf T, Schulz-Menger J. Isometric handgrip exercise during cardiovascular magnetic resonance imaging: set-up and cardiovascular effects. J Magn Reson Imaging. 2013;37:1342–50. https://doi.org/10.1002/jmri.23924.
- 33.Szekanecz Z, Szücs G. Systemic sclerosis increased arterial stiffness as the marker of vascular involvement in systemic sclerosis. J Rheumatol. 2008;35:1329–33. http://www.jrheum.org/content/35/7/1329.long.
- 34.Darr KC, Paul DR, Morgan BJ, Thomas DP. Effects of age and training status on heart rate recovery after peak exercise. Am J Physiol - Hear Circ Physiol. 1988;254:340–3. https://doi.org/10.1152/ajpheart.1988.254.2.H340.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.